Twyla Mosey, PharmD, RPh, FDA Director, Division of Advertising & Promotion Review, Joins Keynote Faculy & Agenda Announced for the 27th Pharma & Med Device Ethics & Compliance Congress

  • A Hybrid Onsite Conference and Internet Event
  • The Leading Forum on Pharmaceutical and Medical Device Ethics and Compliance Issues
  • Sponsored by Pharmaceutical Compliance Forum
  • October 13-16, 2026
  • Washington Hilton, Washington, DC
  • www.PharmaCongress.com

PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com
AGENDA AVAILABLE
Click here for Agenda.

INDIVIDUAL AND GROUP REGISTRATION
Register by August 14 for Early Bird
Click here to register individuals or groups.

FEATURING ANNUAL FDA DIVISION OF ADVERTISING & PROMOTIONAL REVIEW KEYNOTE ADDRESS BY

Twyla Mosey, PharmD, RPh
Director, Division of Advertising & Promotion Review, US Food and Drug Administration, Washington, DC

WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- AUGUST 6, 2026: The Twenty-Seventh Annual Pharmaceutical & Medical Device Ethics and Compliance Congress sponsored by the Pharmaceutical Compliance Forum (PCF) will be held at the Washington Hilton, Washington, DC on October 13-16, 2026. Attendees may attend either virtually online or in person. Onsite attendees will also enjoy both live and post-conference access to the Congress audio/video archive.


THE 2026 27TH ANNUAL CONGRESS FEATURES
  • New half-day Focused Sessions on the afternoon of Tuesday 10/13
  • Over 50 concurrent mini summits and 15 plenary session presentations
  • The PCF-sponsored, Closed-door, invitation-only CCO Roundtable, last year attended by over 100 CCOs
  • The Industry-only Compliance Best Practices Think Tank hosted by PCF
  • A sold-out exhibit hall featuring many innovative ethics and compliance products, programs and initiatives
  • Numerous professional networking opportunities

GOVERNMENT KEYNOTE SPEAKERS

Jacob Foster, JD
Acting Chief, Health Care Fraud Unit, Criminal Division, Fraud Section, US Department of Justice, Washington, DC
Brenna Jenny, JD, MPH
Deputy Assistant Attorney General, Commercial Litigation Branch, Civil Division, US Department of Justice, Washington, DC

Twyla Mosey, PharmD, RPh
Director, Division of Advertising & Promotion Review, US Food and Drug Administration, Washington, DC
Mary E. Riordan, JD
Senior Counsel to the Inspector General, HHS Inspector General, Washington, DC

THE ANNUAL ADVAMED, BIO & PHRMA UPDATE BY

John Delacourt, JD
Deputy GC, VP Health, Regulatory & Commercial Operations, BIO; Former Chief Antitrust Counsel, FTC, Washington, DC
Ida Nassar, JD
Vice President, Assistant General Counsel, Ethics & Compliance, AdvaMed; Former Senior Attorney, Office of Chief Counsel, US Drug Enforcement Administration, Washington, DC
Julie Ritchie Wagner, JD
Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS, Washington, DC

A QUI TAM COUNSEL ROUNDTABLE BY

Mary A. Inman, JD
Partner, Whistleblower Partners; Founding Member & Board Chair, Psst.org; Member of Advisory Board, Whistleblowing Canada Research Society, San Francisco, CA
Linda Severin, JD
Managing Member, Whistleblower Law Collaborative LLC; Former Assistant US Attorney, Southern District of New York, US DPJ, Boston, MA
Gregg Shapiro, JD
Founder, Gregg Shapiro Law, LLC; Former Assistant US Attorney and Chief, Affirmative Civil Enforcement Unit, US Attorney's Office, District of Massachusetts, US DOJ, Boston, MA

ETHICS & COMPLIANCE PROFESSIONALS AND IN-HOUSE COUNSEL

Peter Agnoletto, CPA
Compliance Officer, General Medicines and Consumer Health Care, Sanofi, Bridgewater, NJ
Kaoutar Afif
Manager, Ethics & Compliance, Cardinal Health, Dublin, OH
Brian C. Barry, JD
Vice President, Chief Compliance Officer, Vertex; Former Compliance Officer, US & Canada, EMD Serono, Boston, MA

Allison Benkert, MBA
Sr. Director, Compliance Policies, Training & Investigations, Jazz, Doylestown, PA
Amy Bensten, JD
Head of Investigations for Americas, Ethics & Compliance, Takeda, Cambridge, MA
Brent Boeckmann, MBA
Strategic Advisor, Commercial Immunology, Sanofi; Fmr VP, Eli Lilly - Inproteo Affiliate, Boston, MA

Peter Brensilver, JD
Senior Vice President, Chief Global Commercial Compliance & Risk Counsel, Pfizer, New York, NY
Terra Buckley, JD
Chief Compliance & Ethics Officer, Bristol Myers Squibb; Fmr CCO, LivaNova, Summit, NJ
Sri Burra, MBA
Director, US Ethics and Compliance, Organon; Fmr Ethics & Compliance Lead, North America, Haleon, Malvern, PA

Briana Cabrera, MS, CFE
Senior Director, Global Privacy & Compliance Investigations, Medtronic; Fmr Director, Forensic Audit, Covidien, Miami, FL
Regina Cavaliere, JD
Chief Ethics & Compliance Officer, VP Regulatory & Compliance, Henry Schein, Melville, NY
Maureen Cawley, JD
Senior Director, Corporate Counsel, Incyte; Fmr Global Agreements Attorney, Merck, Philadelphia, PA

Jessica Constant, MS
Associate Director, Compliance, AstraZeneca; Fmr Global Compliance Business Partner, QIAGEN, Washington, DC
Elizabeth Conti, JD
Senior Legal Counsel, Nestlé Health Science, Arlington, VA
Reetu Dandora, JD
SVP, Quality & Regulatory Compliance, AVEO; Fmr Executive Director Strategic Quality Oversight, Merck, Boston, MA

Giulia Del Cane, MS
Head, E&BI Projects and Compliance Officer for Enabling Functions, Global Specialty Care, Sanofi, Boston, MA
Sharon R. Delshad, JD
Senior Director, Legal-Compliance Counsel, Travere Therapeutics; Founder, Rebel Compliance, Del Mar, CA
Jason DiPietro
Senior Manager Compliance Analytics & Transparency Compliance, Lundbeck, Lake Zurich, IL

Colleen Doyle, ACFE
Senior Director, Risk Insights and Management, Novo Nordisk; Fmr Senior Director, Compliance & Risk Insights, Sage, Plainsboro, NJ
Jennifer Dubas, JD
CCO, Jazz; Fmr SVP & CCO, Concore; Fmr SVP & CCO, AmerisourceBergen, Ambler, PA
Kevin Espinoza, MBA
Chief Integrity & Compliance Officer, Indivior; Fmr CCO, Kaleo; Fmr SVP, Boston Scientific, Richmond, VA

Patrice Ettinger, JD, CIPP/US
VP, CPO, Regeneron; Fmr CPO, Pfizer; Fmr CPO, Avon, New York, NY
Yelena Ferreira, JD
Assistant GC & Head of Compliance, Pharmacosmos; Fmr Senior Director, Associate General Counsel, Pacira, Morristown, NJ
Susana Franco, MBA
Director, Field Compliance and Investigations, Lundbeck; Fmr Director of Compliance Operations, Orthofix, Dallas, TX

Rawan Fusisi
Head, Transparency and Third Party Compliance, Indivior; Fmr Transparency and Analytics Manager, Stryker, Washington, DC
Julian Gabbard, JD
Associate GC, Meso Scale; Fmr Head of Legal & Compliance, Kolon; Fmr Sr. Director, Arcellx, Washington, DC
Naveen Ganesh, MA, JD
VP, Global Head of Investigations, Takeda; Fmr Head of Investigations, North America & Global Specialty Care, Sanofi, Boston, MA

Lindsey LaMoria Gavin
Senior Director, Deputy Compliance Officer, Lundbeck; Fmr Compliance Director, Meetings & Events International, Deerfield, IL
Jim Gibney
Vice President, Global Compliance Operations, Regeneron; Fmr Director, Worldwide Programs, Pfizer, Ridgewood, NJ
Jillian A. Gillespie, MBA
Sr. Director, Compliance, Medical & Medical Affairs, Pfizer; Fmr Director, Compliance Business Partner, Seagen, Chicago, IL

Betania Glorio, JD
SVP & CCO, Avidity; Fmr CCO & Head, Group Compliance and Data Privacy, EMD Serono; Fmr Global Head of Compliance, Healthcare, Merck KGaA, Boston, MA
Kate Godfrey, JD, CCEP
Senior VP, Global Chief Compliance Officer, Chief Compliance Officer KSNA, Karl Storz North America, El Segundo, CA
Kimberly Gold, JD
Chief Privacy Officer & Senior Associate GC, Privacy Law, Genentech; Fmr Privacy Secondee, Pfizer, San Francisco, CA

Michele Guerino, MS
Executive Director, Ethics and Compliance Officer, Merck; Fmr Senior Regional Business Director, Cubist, Hopewell, NJ
Tracey Hannon, JD
Director, Compliance Business Partner, Alexion; Fmr Compliance Counsel, Ionis, Boston, MA
Kathryn Harris, JD
Head of US Compliance, Galderma; Fmr Senior Director, Global Compliance, Emergent BioSolutions, Boston, MA

Stefanie L. Hill, JD
Senior Director, Global Ethics & Compliance, Emergent; Fmr Senior Compliance Counsel, Prolacta; Fmr Director, Compliance Counsel, Otsuka, Gaithersburg, MD
Tom Hiney, CIPP/US, CIPM, JD
Head, Digital Ethics & Compliance, US Business Unit, Takeda; Former Privacy Counsel, Blueprint Medicines, Boston, MA
Marla Izbicky, JD
Senior Director, Senior Corporate Counsel, Harmony Biosciences, Chicago, IL

Tahvia Jenkins, JD, CIPPUS
US Privacy Officer & Counsel, Sanofi; Fmr Assistant Counsel, University of California, Cambridge, MA
Kathy Johnson, JD
Vice President, Commercial and Development Legal, Vertex; Fmr, US Legal Counsel Consultant, Takeda, Boston, MA
Melissa (Missy) Kaschak, MS, CPA, CFE, CISA
GRC Operations, Olympus Corporations of the Americas, Center Valley, PA

Abe Kassis, MBA, PhD
Global Head Compliance & Legal Operations, Bausch + Lomb; Fmr Global Compliance Director, Takeda, New York, NY
Geeta Kaveti, MHA, JD
CCO & US General Counsel, Nyxoah; Fmr VP, Chief Compliance & Privacy Officer, Nevro, Vernon Hills, IL
Jeffrey Kawalek, MBA
Chief Compliance Officer, Zambon US; Fmr Deputy CCO US, Jazz; Fmr Board Chair, PCF, New York, NY

Peggy Kruk, HMCC
Compliance Manager, MiMedX; Fmr Director, Compliance, Program Services, Vaniam Group, Dallas, GA
Cheryl Lee, MBA, CHC
Head of Compliance, Cycle; Fmr VP, ESG Strategy & Execution, BMS; Fmr VP, Compliance Worldwide, Celgene, New York, NY
Peter Lee, JD, LLM
Chief Compliance Officer, Kura Oncology; Fmr CCO, Mirati Therapeutics; Fmr CCO, Heron Therapeutics, San Diego, CA

Aaron Lewis, MBA
Director, Legal & Compliance, Cordis; Fmr Director, Compliance Insights, Cardinal Health, Miami Lakes, FL
Melissa T. Lozner, JD
Senior VP, CCO, Regeneron; Fmr CCO, Rafael Holdings; Fmr VP, Ethics, Novartis, Tarrytown, NY
Christian Malias, MBA
Associate Director, Compliance Program Development, Insmed; Fmr Associate Director Compliance Business Partner, Sage, Pittsburgh, PA

Danielle Manner, JD
Chief Privacy Officer and Senior, Associate General Counsel, Gilead; Fmr Senior Privacy Counsel, Pfizer, Chicago, IL
Rosemary McKenna, JD
Executive Director, Regulatory Legal, Organon; Fmr Director, Regulatory-Legal, Merck, Philadelphia, PA
Nick Merker, JD
Vice Preesident, Assistant General Counsel, Chief Privacy Officer & Head of Digital Legal Office, Eli Lilly, Indianapolis, IN

Michelle Murphy
Executive Director, Compliance, Regeneron; Former Consultant, Musculoskeletal Transplant Foundation, New York, NY
Eric Ortman, MBA
Senior Director, Legal Operations Compliance, 4D Molecular; Fmr Senior Director, Legal Operations, BeiGene, Walnut Creek, CA
Alison Page, JD
Assistant General Counsel, Pfizer, New York, NY

Al Park
Senior Compliance Officer, Global Monitoring & Auditing, Jazz; Fmr Global Program Effectiveness, Worldwide Compliance & Business Ethics, Amgen, Phoenix, AZ
Sandra Park, JD
Senior Vice President, Legal & CCO, Vera; Fmr GC & CCO, IDEOlogy Health; Fmr VP, Commercial Legal, Kite, a Gilead Company, Brisbane, CA
Joan Podleski, CCEP, CHPC, CHRC, CHC
VP & CPO, Children’s Health System of Texas; Fmr Director, Institutional Ethics & Compliance Program, Duke University, Dallas, TX

Lauren Ann Pond, JD
Assistant General Counsel, BridgeBio; Fmr Commercial Counsel, Biogen; Fmr Counsel, Takeda, Palo Alto, CA
Hannah Putnam, MHA, CHC, CHRC
Head of Ethics & Compliance Operations, Oncology, Takeda; Fmr Senior Director, Ethics & Compliance, Veloxis, Cambridge, MA
Ariadna Quesada, MSJ
VP, Compliance, Global Compliance & Privacy lead, ZOLL Medical; Fmr Compliance Director, Europe & MEATI, Hillrom, Madrid, Spain

Omar S. Richardson, MBA
Executive Director, Compliance, Shionogi; Fmr Compliance Officer, Grünenthal Group, New York, NY
Megan Roberts, CPA, MS
Head of Integrity & Compliance, Par Health; Fmr Senior Director, Integrity & Compliance, Mallinckrodt, St. Louis, MO
Jaya Saigal
Senior Director, C&E Policy, Education, Communications, Culture of Integrity and Ombuds, Bristol Myers Squibb, Princeton, NJ

Alexis Shaw, ACFE
Deputy CCO, Paratek; Fmr Compliance Officer, Endo; Fmr Global Compliance Investigations Manager, Boston Scientific, King of Prussia, PA
R. Brett Short, CHC, CHPC, CHRC
CCO & CPO, University of Kentucky; Past Chair, Health Care Compliance Association, Lexington, KY
Jesse Siegel, JD
Head of Business Ethics, Americas, Ipsen; Fmr Senior Counsel, Neurology & Immunology, EMD Serono, Cambridge, MA

Matthew Stasiunas, PMP, CCEP, LPEC
RAMP & Project Management Lead, Indivior; Fmr Senior Specialist, Integrity and Compliance, Kaléo, Richmond, VA
Ronald Strauss, CIPM
Vice President Compliance, MiMedx; Fmr Sales Leader, Eli Lilly Specialty, Marietta, GA
Kelly J. Tope, JD, MBA
Head, Ethics & Business Integrity Governance, Sanofi; Fmr Head, USBU Ethics & Compliance, Monitoring & Reporting Operations, Takeda, Boston, MA

Emily Treanor, JD
Head of Global Investigations & Enterprise Risk Management, Alnylam; Former Senior Legal Counsel, Global Compliance, Hess, Washington, DC
Natasha Trifun, JD
Head of Enterprise Compliance & Risk and Privacy, AstraZeneca; Fmr Corporate Counsel, Brazil Compliance Officer, Pfizer, Boston, MA
Akosua Tuffour-Brown, JD
Corporate Counsel, U.S. General Medicines, Sanofi, Washington, DC

Betsy Wade, MPH, CHC, CHPC, CAN
Chief Compliance & Ethics Officer, Signature Healthcare; Board & Treasurer, Health Care Compliance Association, Louisville, KY
Achsah Warren, MSJ
Vice President Compliance, Sumitomo; Fmr Vice President Compliance, Urovant; Fmr Senior Compliance Manager, Allergan, Irvine, CA
Kelly Willenberg, MBA, DBA, CHC, CHRC
Chief Executive Officer, Kelly Willenberg & Assocs.; Board & Second Vice Chair, Health Care Compliance Association, Greenville, SC

Elizabeth Weiss, JD
VP, Chief Compliance & Privacy Officer, Invivyd; Fmr Head of Compliance for Americas & EMEA, Lupin; Fmr Assistant GC, Pfizer, Livingston, NJ
Amy Wilson, MBA, MSJ
VP & CCO, Esperion; Fmr Head of US Compliance, MorphoSys; Fmr Director, Enterprise Compliance, Alexion, Boston, MA
Suki Wiltman
Vice President, Global Ethics & Compliance, Ipsen; Fmr Business Partner, Governance, Ethics & Compliance, GSK, Toronto, Canada

Stacy E. Yeung, JD
VP & GC, SELLAS; Fmr Assistant General Counsel, Arena Pharmaceuticals; Fmr Deputy General Counsel, DBV Technologies, New York, NY
Olga Zinavenka, CPA, MBA
Head of Compliance Operations, Keenova; Fmr Executive Director, Head of Compliance Operations, Endo, Paoli, PA


INDIVIDUAL AND GROUP REGISTRATION
Register by August 14 for Early Bird
Click here to register individuals or groups.

AGENDA AVAILABLE
Click here for Agenda.

SPONSORED BY


PRODUCED BY


PCF BOARD

Donna White, CCEP
Vice President and Compliance Officer, Chiesi Farmaceutici S.p.A., Americas Region (Board Chair)


Christie Camelio
Senior Vice President and Chief Compliance Officer, Insmed


Jill Dailey, JD
Vice President & Chief Compliance Officer, Oncology, Menarini Stemline


Anisa Dhalla
Vice President, Global Head, Ethics and Business Integrity, UCB


Daryl Kreml, JD
Head of Ethics & Compliance, Global Oncology, Takeda


Melissa T. Lozner, JD
Senior Vice President, Chief Compliance Officer, Regeneron

MEDICAL DEVICE EXECUTIVE COMMITTEE

Sujata Dayal, JD
Independent Board Director, Emergent BioSolutions; Senior Advisor


JJ Kuhn, JD
Senior Vice President and Chief Ethics & Compliance Officer, Solventum


Mona Peterson Rosow, JD, MPH
Vice President, Global Risk, Ethics & Compliance Officer, Mozarc Medical


Tara Shewchuk, JD, LLM
Senior Vice President, Chief Privacy, Integrity & Compliance Officer, Medtronic


Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker

MEDIA PARTNERS




GRANTORS
PLATINUM


GOLD














SILVER






















BRONZE

















































FORMER GOVERNMENT OFFICIALS

Corey R. Amundson, JD
Partner, King & Spalding; Fmr Head, Public Integrity Section, US DOJ; Fmr Acting US Attorney, Middle District of Louisiana, Washington, DC
Jennifer L. Bragg, JD
Partner, Latham and Watkins; Fmr Associate Chief Counsel for Enforcement, Office of Chief Counsel, US FDA, Washington, DC
Hui Chen, JD
Co-Founder, Culture. Data. Ethics; Fmr Compliance Counsel Expert, US DOJ; Fmr Assistant General Counsel, Pfizer, Honolulu, HI
Deborah A. Curtis, JD
Partner, Arnold & Porter; Fmr Deputy GC, CIA; Fmr Deputy Chief, Counterespionage, US DOJ, Washington, DC
Greg Demske, JD
Partner, Goodwin Procter; Fmr Chief Counsel, Office of Inspector General, US HHS, Washington, DC

Sarah A. Franklin, JD
Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling; Fmr Attorney, US FTC, Washington, DC
Gregory T. Garcia
Executive Director, Cybersecurity Working Group, Health Sector Coordinating Council; Fmr Assistant Secretary for Cybersecurity, US DHS, Washington, DC
Gejaa T. Gobena, JD
Partner, Hogan Lovells Cadwalader; Fmr Deputy Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC
Christine Gordon, JD
Vice President, Risk, Assurance, & Compliance and Chief Compliance Officer, Olympus; Fmr Assistant District Attorney, Philadelphia District Attorney’s Office, Bethlehem, PA
Kristie Champlin Gurley, JD
Partner Covington & Burling; Fmr Counsel, Office of the General Counsel, CMS Division, US Department of Health and Human Services (HHS), Washington, DC

Sarah M. Hall, JD
Partner, Member of the Firm, Epstein Becker Green; Fmr Trial Attorney, Fraud Section, Criminal Division, US Department of Justice, Washington, DC
Shannon Kelley, JD
EVP, Chief Legal Officer, Madrigal; Fmr VP, Head of Compliance, North America & Global Specialty Care GBU, Sanofi; Fmr AUSA & Deputy Chief of Litigation, US Attorney's Office District of Massachusetts, Boston, MA
John Kelly, JD
Partner & Chair, Healthcare Practice, Barnes & Thornburg; Fmr Asst. Chief for Health Care Fraud, Criminal Division, US DOJ, Washington, DC
Barbara A. Leaf, JD
Senior International Policy Advisor, Arnold & Porter; Fmr Special Assistant to the President; Fmr US Ambassador, UAE, Washington, DC
Christine Moundas, JD, MPH
Healthcare & Data Partner & Co-Head, Digital Health Initiative, Ropes & Gray; Fmr Analyst, Office of Inspector General, US HHS, New York, NY

Preeya Noronha Pinto, JD
Partner, DLA Piper; Fmr Acting General Counsel, US Department of Health and Human Services, Washington, DC
Kenneth A. Polite, Jr, JD
Partner & Global Co-leader, White Collar Defense, Sidley Austin LLP; Fmr Assistant Attorney General, Criminal Division, US DOJ, Washington, DC
David J. Scott, MS
Managing Director, Forensic & Integrity Services, EY; Fmr Assistant Director, Counterterrorism, & Head, Operations Branch, National Cyber Investigative Joint Task Force, FBI, Leesburg, VA
Diane Seol, JD
Of Counsel, Choate Hall & Stewart; Fmr Assistant United States Attorney, Affirmative Civil Enforcement Unit, US Attorney’s Office, District of Massachusetts, Boston, MA
Michael L. Shaw, JD
Global Head of Compliance, Privacy and Risk, ZS; Fmr VP & CO, GlaxoSmithKline; Fmr Senior Counsel, OIG US HHS, Princeton, NJ

Amanda Strachan, JD
Partner, WilmerHale; Fmr AUSA & Chief, Criminal Division, US Attorney’s Office, District of Massachusetts, US DOJ, Boston, MA
Julie K. Taitsman, MD, JD
Managing Director, BDO, US; Fmr CMO, HHS Office of Inspector General; Fmr Special Counsel, US Senate Committee on Finance, Washington, DC
Jane H. Yoon, JD
Partner, Litigation Department, Paul Hastings; Fmr Assistant United States Attorney, US Attorney’s Office, New Jersey, New York, NY

COMPLIANCE EXPERTS, ADVISORS AND COUNSEL

Warren T. Allen II, JD
Principal, Miles & Stockbridge, Washington, DC
David Amendola
Director, Life Sciences, Resolution Economics; Fmr Global Compliance, ConvaTec, New York, NY
Eliza L. Andonova, JD
Partner, Global Regulatory, Hogan Lovells Cadwalader, Washington, DC
Minna Bak, MBA
Director, HELIO, Boston, MA
Brett Barlag, MBA
Senior Managing Director, Healthcare Risk Management and Advisory, FTI Consulting, New York, NY

Samantha Barrett Badlam, JD
Partner, Litigation & Enforcement Group, Ropes & Gray, Washington, DC
Yogesh Bahl, MBA
Practice Leader, Resolution Life Sciences; CFO & Head of Investor Relations, IACTA, New York, NY
Melissa Bianchi, JD
Partner and Leader, Firm's Digital Health Initiative, Hogan Lovells Cadwalader, Washington, DC
David M. Blank, JD
Partner, Arnall, Golden, Gregory; Fmr Senior Counsel, HHS; Fmr Special AUSA, Southern District Mississippi, Washington, DC
Craig B. Bleifer, JD
Partner, McGuire Woods; Fmr Corporate VP, GC North America; Novo Nordisk, New York, NY

Brian A. Bohnenkamp, MHA, JD
Partner, FDA and Life Sciences, King & Spalding, Washington, DC
Eric Bolesh
Chief Operating Officer, Cutting Edge Information, Research Triangle Park, NC
Mary Capizzi, JD, MBA
Partner, Faegre Drinker; General Counsel, International Pharmaceutical & Medical Device Privacy Consortium, Washington, DC
Jennifer Ceglinski, JD, CFE
Manager, Forensic & Integrity Services, EY, Charlotte, NC
Matthew Chandler, JD
Director, Epsilon Life Sciences, Richmond, VA

Michael Clarke, JD, CCEP, NACD.DC®
Principal, Jaeger-Plymouth; Retired VP, Deputy GC & Global CCO, ConvaTec, Bridgewater, NJ
Chris Cobourn, MS
Managing Director, Government Programs Practice Lead, Helio Health Group, Placida, FL
Benjamin Correa, JD
Partner, Food, Drug & Medical Device, Sidley Austin, Washington, DC
Zachary Coseglia, JD
Co-Founder, Culture. Data. Ethics; Fmr VP & AGC, Monitoring, Analytics and Digital, Pfizer, Boston, MA
Layla Covington, JD
Senior Manager, Compliance Consulting, Cresen; Fmr Manager, Aggregate Spend, Genentech, Chicago, IL

Clarissa Crain
Managing Director, Deloitte, Phoenixville, PA
Kari Czeszewski, CHC
Associate, Epsilon Life Sciences, New York, NY
Jamie E. Darch, JD
Partner, HIPAA and State Data Privacy & Cybersecurity Law, Ropes & Gray, Chicago, IL
Meena Datta, JD
Partner and Global Co-leader, Healthcare Practice, Sidley Austin, Chicago, IL
Mahnu V. Davar, MA, JD
Partner and Co-chair, Life Sciences & Healthcare Regulatory, Arnold & Porter, Washington, DC

Audrey DeGuarde, MSJ
Vice President, General Manager, Commercial Compliance, MediSpend, Morristown, NJ
Edward Diskant, JD
Partner, McDermott Will & Schulte; Fmr AUSA, Southern District of New York, US DOJ, New York, NY
Stefanie A. Doebler, JD
Partner and Co-Chair, Health Care Practice Group, Covington & Burling, Washington, DC
Joy Dowdle, JD
Partner, Litigation Department, Paul Hastings and Co-Chair of the Houston Office, Houston, TX
Kip Ebel, MBA
Principal, Forensic & Integrity Services, EY, New York, NY

Aurelie Ercoli, LLM, PhD
Partner, Life Sciences Practice Group, DLA Piper, US, Washington, DC
Ronnie H. Feldman
Founder & CEO, L&E: Comedians Who Improve Compliance, Chicago, IL
Alison J. Fethke, JD
Member, Epstein Becker Green; Fmr Counsel, Legal Regulatory & Compliance, AbbVie, Chicago, IL
David Fisher, MS
President, TDI Solutions; Fmr VP & General Manager, Cyber Innovations, Battelle, Washington, DC
Sara K. Frank, JD
Principal, Life Science Practice, Choate Hall & Stewart, Boston, MA

Gary F. Giampetruzzi, JD
Partner & Global Chair Life Sciences, Paul Hastings; Fmr VP & AGC, Head of Government Investigations, Pfizer, New York, NY
John Gitas, MBA
Principal, US Advisory, Healthcare and Life Sciences, KPMG, New York, NY
Noah C. Goldstein, JD
Counsel, Pharma, Biotech & Medical Device Legal, Regulatory, & Compliance, Porzio Bromberg & Newman, Westborough, MA
Anthony Greco, MBA
Managing Director, Pharmaceutical & Life Sciences Advisory Services, PwC, Philadelphia, PA
Asha Green, JD, MPA
Director, US Compliance, Ferring; Fmr Global Head, I&C Risk Assessment & Senior Business Advisor, Indivior, Parsippany, NJ

Adam Greene, JD, MPH
Partner and Co-chair, Health Information & HIPAA Practice, Davis Wright Tremaine LLP; Fmr Senior Health Information Technology and Privacy Specialist, Office for Civil Rights, HHS, Washington, DC
Neeraj Gupta, MBA
President, Chief Technology Officer, Cresen Solutions, Chester Springs, PA
Kris Hall, JD, CIPP/CIPM
Managing Director, Dovetail; Fmr VP, Chief Privacy Officer, Celgene; Fmr VP, Head of Privacy, Shire, Bridgton, ME
Kristin M. Hicks, JD
Partner, Life Sciences & Healthcare Regulatory, Arnold & Porter, Washington, DC
Emily F. Hodge, JD
Partner, Life Science Practice, Choate, Hall & Stewart, Boston, MA

Casey J. Horton, CFE
Managing Director, Epsilon Life Sciences; Fmr Director, Compliance Operations, AbbVie, Chicago, IL
Jeff Hyre
Vice President Sales, Healthcare & Life Sciences, Global Relay, Denver, CO
Katie Jacyna
Vice President, Chief Product Officer, HELIO, Denver, CO
Mark A. Jensen, JD
Partner, Special Matters and Government Investigations, King & Spalding, Washington, DC
Erin Brown Jones, MA, JD
Partner, Latham & Watkins, Washington, DC

Marci Juneau, MBA
A Founding Partner, Helio Health Group, Atlanta, GA
Kristin Graham Koehler, JD
Managing Partner, DC Office & Executive Committee Member, Sidley Austin, Washington, DC
Olivia Krzeminski, JD
Director of Compliance & Legal Research, G&M Health, Somerset, NJ
Rebekah Latchis, JD
VP, Risk Intelligence & Investigations - Office of Integrity, Privacy and Compliance, Medtronic, Washington, DC
Stephanie Lewko, CFE
Managing Director, Ankura, Washington, DC

Jeffrey Low, RPh, MHA
Director, Ankura; Fmr VP, Clinical Services, Magellan Health; Fmr Director, Medicare Services, CVS/Caremark, Phoenix, AZ
Courtney Lyles
Manager, Privacy and Data Protection, Dovetail Consulting Group, Atlanta, GA
Gabe Maldoff, JD
Partner, Data, Privacy, and Cybersecurity practice, Goodwin Procter; Adjunct Professor, Maine Law School, Washington, DC
Robert Melillo, JD
Co-founder and Managing Director, G&M Health, Cocoa Beach, FL
Brook Mishler, RN, MSN
Global Director of Compliance Solutions, Life Sciences, Case IQ; Fmr Compliance Officer for the Americas, Cordis, Ontario, Canada

Tracy Mumpower
Director, Life Science Revenue, Government Pricing, HELIO; Fmr Manager, Commercial Contract Admin, King, Bristol, VA
Katherine C. Norris, MPA
Senior Managing Director, Life Sciences Compliance, Disputes & Economics, Ankura, Honolulu, HI
Daniel O’Connor
Senior Vice President, NXLevel Compliance; Angel Investor, Angel Investor Forum, Lambertville, NJ
Michael T. O'Connor
Chief Executive Officer, Qordata; Angel Investor, Angel Investor Forum, New York, NY
John Poulin
Chief Technology Officer and Partner, Helio Health Group, Boston, MA

Adam T. Oakley
Senior Director, Potomac River Partners, Washington, DC
Saraswatha Lalitha Putcha, MA
Director, Product & Client Delivery, Cresen Solutions, Philadelphia, PA
John S. Rah, JD
Counsel and Head, Life Sciences Compliance Practice, Potter & Murdock, Potomac, MD
Georgia Ravitz, JD
Partner, FDA & Healthcare Regulatory, Orrick, Herrington & Sutcliffe, Washington, DC
Nikki Reeves, JD
Partner and Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding, Washington, DC

Michael Reyes
Director, Risk & Regulatory Consulting, PwC; Fmr Analyst, Compliance Analytics, Edwards Lifesciences, Dallas, TX
Brian Riewerts, MPA
Partner, Pharmaceutical and Life Sciences Risk and Regulatory Leader, PwC, Washington, DC
Russell Rose, JD
Managing Director, Life Sciences Advisory, Deloitte, Dallas, TX
Mark Scallon, MHA
Principal, Risk Advisory, Life Sciences Consulting, Compliance and Ethics Market Leader, Baker Tilly, Richmond, VA
Russell Schaefer, MBA
Managing Director, BCG, Washington, DC

Jeffrey Scott, JD
Of Counsel, DLA Piper; Fmr Lead Compliance Counsel Digital, Pfizer, Philadelphia, PA
Kala Shankle, JD
VP, Regulatory, Healthcare Distribution Alliance; President Elect, American Society Pharmacy Law, Wash., DC
Paul Silver
Principal, Life Sciences Regulatory, Legal & Compliance Leader, Deloitte, Atlanta, GA
Emily (Jaffe) Singh
Partner, Global Spend Transparency Practice Leader, PwC, Chicago, IL
Laura A. Skinner, MBA
Managing Director, Life Sciences Consulting, Paul Hastings; Managing Director, Rare Disease Compliance Consortium, New York, NY

Ravneet Talwar, MBA
Senior Manager, Life Sciences & Healthcare Consulting Group, Paul Hastings, New York, NY
Stephanie Trunk, JD
Partner, Life Science Practice Group, Arent Fox Schiff; Fmr Legal Counsel, Catalyst Health Solutions, Washington, DC
Brian Van Hoy, RPh
Vice President of Compliance, G&M Health; Fmr Director Compliance & Ethics, Eli Lilly, Somerset, NJ
L. Stephan Vincze, JD, LLM, MBA
President & CEO, TRESTLE Compliance; Fmr SVP & CCO, Warner Chilcot; Fmr VP & CCO, TAP, Boston, MA
Erin Wagenberg, CIPP/US, CIPP/E, CIPT
Director, Dovetail Consulting Group; Fmr Deputy Privacy Officer, Deloitte Global, Atlanta, GA

Shannon Walker
Executive Vice President, Thought Leadership & Strategy, Case IQ; Founder and President, Whistleblower Security, Ontario, Canada
Robert A. Wells, JD
Health Care Regulatory Shareholder, Chair, Health Law and Government Solutions, Baker, Donelson, Bearman, Caldwell & Berkowitz, Baltimore, MD
Sarah L. Whipple, JD
Principal, WhipEdge Solutions; Member, Rare Disease Compliance Consortium; Fmr VP, GCCO, Apellis, Needham, MA
Kelly Willenberg, MBA, DBA, CHC
Chief Executive Officer, Kelly Willenberg and Associates, Greenville, SC
Jacob Wolf, MBA
Chief Commercial Officer, Cresen Solutions, Orlando, FL

Christina Woods, MHA
Partner, Pharmaceutical and Life Sciences Risk & Regulatory Consulting, PwC, New York, NY
Heather Young, JD
Senior Director, Compliance Officer, Global Business Partner, Olympus; Fmr Philadelphia Assistant DA, Center Valley, PA
Cobun Zweifel-Keegan, JD
Managing Director, IAPP; Fmr Deputy Director, Privacy Initiatives, Better Business Bureau, Washington, DC

NEW THIS YEAR: FEATURING 5 IN-DEPTH, HALF-DAY, AFTERNOON
FOCUSED SESSIONS, 1:00-5:30 PM ON TUESDAY 10/13
(Included in your Congress registration.)
Focused Session 1: Whistleblower Complaints: From Hotline to Resolution: Managing Internal Investigations, Whistleblower Risk & Escalation Decisions
  • Explore leading practices for managing hotline complaints, conducting effective internal investigations, assessing whistleblower risk, making escalation decisions, and navigating today's evolving enforcement environment.
  • Featuring a Qui Tam Counsel Roundtable
Focused Session 2: Pharmaceutical and Medical Device Advanced Privacy and Security/Cybersecurity Updates
  • Gain practical insights into the latest privacy, cybersecurity, and data protection developments impacting life sciences organizations, including advanced compliance strategies and emerging regulatory expectations.
  • Featuring Presentations by International Association of Privacy Professionals & International Pharma & Medical Device Privacy Consortium
Focused Session 3: Managing Medical-Commercial Interactions: Strategic Collaboration, Evolving Roles & Risk-Based Governance
  • Examine how leading organizations are strengthening collaboration between Medical Affairs and Commercial while maintaining Medical independence, managing evolving field-based roles, and implementing effective governance models.
  • Featuring Have We Become Too Restrictive? Rethinking Medical-Commercial Governance for the Next Era
Focused Session 4: AI in Action: Real-World Compliance Case Studies from the Front Lines of AI Use in Life Science Compliance Departments
  • Hear directly from compliance leaders who are using artificial intelligence to enhance monitoring, investigations, policy development, training, and other compliance activities through practical, real-world case studies.
  • Featuring the Health Care Compliance Association Presents: Advanced Strategies in Using AI to Monitor and Improve Compliance
Focused Session 5: Government Pricing Fundamentals for Compliance Officers: Navigating Today's Evolving Pricing & Contracting Landscape
  • Build a foundational understanding of government pricing while exploring the latest developments affecting pricing, contracting, reimbursement, and compliance in today's rapidly changing regulatory environment.
  • Featuring session on the new world of tariffs, mist favored nations, TrumpRX, Medicare drug price negotiation etc.

CONGRESS REGISTRATION

For Congress registration information, visit www.pharmacongress.com/registration-splash/, email reginfo@hcconferences.com, or call 800-503-7419.


FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.

For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.